$150 million punitive charges on a TRT lawsuit
$150 million punitive charges on a TRT lawsuit

Introduction
The very first bellwether trial for TRT lawsuits ended in a mistrial which involved a plaintiff whose allegation against AndroGel was that it caused his heart attack, thereby bringing a pause phase. But the $150 Million verdict to be paid as punitive damage by AbbVie to an Oregon man, under the claim of false marketing is big news that brings a lot of hope to the plaintiffs. Though the federal jury has not held AbbVie responsible for the alleged injury, this Chicago verdict can undoubtedly be considered as a strong signal to alert AbbVie and makes the battle turn positively towards the Plaintiffs. This verdict will now help thousands of TRT cases to move in the just and right direction. Neural IT has hands-on experience in medical reviews and can be a potential partner for law firms looking forward to litigating TRTs.
Latest News
Cencora Directors Settle Opioid Oversight Case for $111M
Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids…
Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients
A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…
FDA Adds New Warnings on Long-Term Opioid Risks
Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.
…